Paper38931908
Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy.
Isowa M and 5 others. Pharmaceutics, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy. Papers, record 38931908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38931908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18623084 | Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18623084 | PubMed |
| 2 | 33347611 | Revisiting the Warburg effect: historical dogma versus current understanding. | J Physiol | 2021 | https://conductscience.org/library/papers/33347611 | PubMed |
| 3 | 18092339 | Bioactive food components and cancer risk reduction. | J Cell Biochem | 2008 | https://conductscience.org/library/papers/18092339 | PubMed |
| 4 | 27262332 | Phytochemicals as Adjunctive with Conventional Anticancer Therapies. | Curr Pharm Des | 2016 | https://conductscience.org/library/papers/27262332 | PubMed |
| 5 | 28095711 | Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice. | J Enzyme Inhib Med Chem | 2017 | https://conductscience.org/library/papers/28095711 | PubMed |
| 6 | 26610440 | Ursolic Acid--A Pentacyclic Triterpenoid with a Wide Spectrum of Pharmacological Activities. | Molecules | 2015 | https://conductscience.org/library/papers/26610440 | PubMed |
| 7 | 26341193 | Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. | Drug Resist Updat | 2015 | https://conductscience.org/library/papers/26341193 | PubMed |
| 8 | 35428370 | Understanding of cell death induced by the constituents of Taxus yunnanensis wood. | Sci Rep | 2022 | https://conductscience.org/library/papers/35428370 | PubMed |
| 9 | 31467365 | Alkaliptosis: a new weapon for cancer therapy. | Cancer Gene Ther | 2020 | https://conductscience.org/library/papers/31467365 | PubMed |
| 10 | 25305622 | Studies on the binding of fulvic acid with transferrin by spectroscopic analysis. | Spectrochim Acta A Mol Biomol Spectrosc | 2015 | https://conductscience.org/library/papers/25305622 | PubMed |
| 11 | 29453373 | Dormancy release and germination of Taxus yunnanensis seeds during wet sand storage. | Sci Rep | 2018 | https://conductscience.org/library/papers/29453373 | PubMed |
| 12 | 31590362 | Curcumin and Cancer. | Nutrients | 2019 | https://conductscience.org/library/papers/31590362 | PubMed |
| 13 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 14 | 27697635 | Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27697635 | PubMed |
| 15 | 11498364 | pH and drug resistance in tumors. | Drug Resist Updat | 2000 | https://conductscience.org/library/papers/11498364 | PubMed |
| 16 | 8847885 | Pharmacology of oleanolic acid and ursolic acid. | J Ethnopharmacol | 1995 | https://conductscience.org/library/papers/8847885 | PubMed |
| 17 | 9022122 | Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. | Cancer Lett | 1997 | https://conductscience.org/library/papers/9022122 | PubMed |
| 18 | 28912578 | Tumour acidosis: from the passenger to the driver's seat. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/28912578 | PubMed |
| 19 | 8306331 | Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. | Cancer Res | 1994 | https://conductscience.org/library/papers/8306331 | PubMed |
| 20 | 30247761 | Higher diet-dependent acid load is associated with risk of breast cancer: Findings from the sister study. | Int J Cancer | 2019 | https://conductscience.org/library/papers/30247761 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38931908
GET https://conductscience.org/api/papers/v1/38931908/references?page=2